|
 |
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Lipid Research, Vol. 47, 883-891, May 2006
Copyright © 2006 by American Society for Biochemistry and Molecular Biology
Thematic Review |
Thematic review series: Lipid Posttranslational Modifications CAAX modification and membrane targeting of Ras
Department of Medicine, Cell Biology & Pharmacology, New York University School of Medicine, New York, NY 10016
Published, JLR Papers in Press, March 16, 2006.
1 To whom correspondence should be addressed. e-mail: philim01{at}med.nyu.edu
Proteins that terminate with a consensus sequence known as CAAX undergo a series of posttranslational modifications that include polyisoprenylation, endoproteolysis, and carboxyl methylation. These modifications render otherwise hydrophilic proteins hydrophobic at their C termini such that they associate with membranes. Whereas prenylation occurs in the cytosol, postprenylation processing is accomplished on the cytoplasmic surface of the endoplasmic reticulum and Golgi apparatus. Among the numerous CAAX proteins encoded in mammalian genomes are many signaling molecules such as monomeric GTPases, including the Ras proteins that play an important role in cancer. In the course of their processing, nascent Ras proteins traffic from their site of synthesis in the cytosol to the endomembrane and then out to the plasma membrane (PM) by at least two pathways. Recently, retrograde pathways have been discovered that deliver mature Ras from the PM back to the Golgi. The Golgi has been identified as a platform upon which Ras can signal. Thus, the subcellular trafficking of Ras proteins has the potential to increase the complexity of Ras signaling by adding a spatial dimension. The complexity of Ras trafficking also affords a wider array of potential targets for the discovery of drugs that might inhibit tumors by interfering with Ras trafficking.
Supplementary key words farnesylation • trafficking • carboxyl methylation
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Subramaniam, K. M. Sixt, R. Barrow, and S. H. Snyder Rhes, a Striatal Specific Protein, Mediates Mutant-Huntingtin Cytotoxicity Science, June 5, 2009; 324(5932): 1327 - 1330. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Sargiannidou, N. Vavlitou, S. Aristodemou, A. Hadjisavvas, K. Kyriacou, S. S. Scherer, and K. A. Kleopa Connexin32 Mutations Cause Loss of Function in Schwann Cells and Oligodendrocytes Leading to PNS and CNS Myelination Defects J. Neurosci., April 15, 2009; 29(15): 4736 - 4749. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. P. Wright, H. Court, A. Mor, I. M. Ahearn, P. J. Casey, and M. R. Philips Topology of Mammalian Isoprenylcysteine Carboxyl Methyltransferase Determined in Live Cells with a Fluorescent Probe Mol. Cell. Biol., April 1, 2009; 29(7): 1826 - 1833. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Liu, R. K. Meray, T. N. Grammatopoulos, R. A. Fredenburg, M. R. Cookson, Y. Liu, T. Logan, and P. T. Lansbury Jr. Membrane-associated farnesylated UCH-L1 promotes {alpha}-synuclein neurotoxicity and is a therapeutic target for Parkinson's disease PNAS, March 24, 2009; 106(12): 4635 - 4640. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. A. Flom, M. Lemieszek, E. A. Fortunato, and J. L. Johnson Farnesylation of Ydj1 Is Required for In Vivo Interaction with Hsp90 Client Proteins Mol. Biol. Cell, December 1, 2008; 19(12): 5249 - 5258. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Barrowman, C. Hamblet, C. M. George, and S. Michaelis Analysis of Prelamin A Biogenesis Reveals the Nucleus to be a CaaX Processing Compartment Mol. Biol. Cell, December 1, 2008; 19(12): 5398 - 5408. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. J. Newton, F. M. Sansom, J. Dao, C. Cazalet, H. Bruggemann, C. Albert-Weissenberger, C. Buchrieser, N. P. Cianciotto, and E. L. Hartland Significant Role for ladC in Initiation of Legionella pneumophila Infection Infect. Immun., July 1, 2008; 76(7): 3075 - 3085. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Lahoz and A. Hall DLC1: a significant GAP in the cancer genome Genes & Dev., July 1, 2008; 22(13): 1724 - 1730. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Bossard, D. Bresson, R. S. Polishchuk, and V. Malhotra Dimeric PKD regulates membrane fission to form transport carriers at the TGN J. Cell Biol., December 17, 2007; 179(6): 1123 - 1131. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Chen, K. J. McQuade, X.-J. Guan, P. A. Thomason, M. S. Wert, J. B. Stock, and E. C. Cox Isoprenylcysteine Carboxy Methylation Is Essential for Development in Dictyostelium discoideum Mol. Biol. Cell, October 1, 2007; 18(10): 4106 - 4118. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. L. Kilpatrick and J. D. Hildebrandt Sequence Dependence and Differential Expression of G{gamma}5 Subunit Isoforms of the Heterotrimeric G Proteins Variably Processed after Prenylation in Mammalian Cells J. Biol. Chem., May 11, 2007; 282(19): 14038 - 14047. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. F. Leung, R. Baron, B. R. Ali, A. I. Magee, and M. C. Seabra Rab GTPases Containing a CAAX Motif Are Processed Post-geranylgeranylation by Proteolysis and Methylation J. Biol. Chem., January 12, 2007; 282(2): 1487 - 1497. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Roelofs, K. Thompson, S. Gordon, and M. J. Rogers Molecular mechanisms of action of bisphosphonates: current status. Clin. Cancer Res., October 15, 2006; 12(20): 6222s - 6230s. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |